Skip to main content
Log in

The impact of statins on the intensity of phlebotomies in polycythemia vera

Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Marchioli R, Finazzi G, Specchia G, Cacciola R, Cavazzina R, Cilloni D, de Stefano V, Elli E, Iurlo A, Latagliata R, Lunghi F, Lunghi M, Marfisi RM, Musto P, Masciulli A, Musolino C, Cascavilla N, Quarta G, Randi ML, Rapezzi D, Ruggeri M, Rumi E, Scortechini AR, Santini S, Scarano M, Siragusa S, Spadea A, Tieghi A, Angelucci E, Visani G, Vannucchi AM, Barbui T, CYTO-PV Collaborative Group (2013) Cardiovascular events and intensity of treatment in polycythemia vera. N Engl J Med 368:22–33

    Article  CAS  Google Scholar 

  2. Barbui T, Tefferi A, Vannucchi AM, Passamonti F, Silver RT, Hoffman R, Verstovsek S, Mesa R, Kiladjian JJ, Hehlmann R, Reiter A, Cervantes F, Harrison C, Mc Mullin MF, Hasselbalch HC, Koschmieder S, Marchetti M, Bacigalupo A, Finazzi G, Kroeger N, Griesshammer M, Birgegard G, Barosi G (2018) Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet. Leukemia 32(5):1057–1069

    Article  Google Scholar 

  3. Hasselbalch HC, Riley CH (2006) Statins in the treatment of polycythaemia vera and allied disorders: an antithrombotic and cytoreductive potential? Leuk Res 30(10):1217–1225

    Article  CAS  Google Scholar 

  4. Griner LN, McGraw KL, Johnson JO, List AF, Reuther GW (2013) JAK2-V617F-mediated signalling is dependent on lipid rafts and statins inhibit JAK2-V617F-dependent cell growth. Br J Haematol 160(2):177–187 1426

    Article  CAS  Google Scholar 

  5. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau M et al (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127:2391–2405

    Article  CAS  Google Scholar 

  6. Demuynck T, Verhoef G, Delforge M, Vandenberghe P, Devos T (2019) Polycythemia vera and hydroxyurea resistance/intolerance: a monocentric retrospective analysis. Ann Hematol 98(6):1421–1426

    Article  CAS  Google Scholar 

  7. Boccia RV, Stein B, Mesa RA, Naim AB, Cordaro JA, Peng W et al (2015) Burden of phlebotomy in patients with polycythemia vera in the United States: baseline data from the REVEAL study. Blood 126(23):5187

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ivan Krečak.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethics

The study was approved by all three Institutional Review Boards and performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

Informed consent

Due to the retrospective nature of the study, the patients’ informed consent was not obtained.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Krečak, I., Holik, H., Morić-Perić, M. et al. The impact of statins on the intensity of phlebotomies in polycythemia vera. Ann Hematol 99, 911–912 (2020). https://doi.org/10.1007/s00277-020-03950-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-020-03950-6

Navigation